These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25542055)

  • 1. [Drugs news].
    Bejan-Angoulvant T; Beau-Salinas F; Lengellé C; Cissoko H; Jonville-Béra AP
    Arch Pediatr; 2015 Feb; 22(2):211-4. PubMed ID: 25542055
    [No Abstract]   [Full Text] [Related]  

  • 2. Pregnancy and fetal outcomes after paternal exposure to azathioprine, methotrexate or mycophenolic acid: a critically appraised topic.
    Garritsen FM; van den Broek MPH; van Zuilen AD; Fidder HH; de Bruin-Weller MS; Spuls PI
    Br J Dermatol; 2017 Apr; 176(4):866-877. PubMed ID: 28418137
    [No Abstract]   [Full Text] [Related]  

  • 3. [Isotretinoin and pregnancy].
    Revuz J
    Ann Dermatol Venereol; 2000 Oct; 127(10):797-8. PubMed ID: 11060380
    [No Abstract]   [Full Text] [Related]  

  • 4. What is the chance of a normal pregnancy in a woman whose fetus has been exposed to isotretinoin?
    Sladden MJ; Harman KE
    Arch Dermatol; 2007 Sep; 143(9):1187-8. PubMed ID: 17875883
    [No Abstract]   [Full Text] [Related]  

  • 5. Teratogenicity of isotretinoin.
    Lancaster PA
    Lancet; 1988 Nov; 2(8622):1254-5. PubMed ID: 2903987
    [No Abstract]   [Full Text] [Related]  

  • 6. Teratogenicity of isotretinoin and etretinate.
    Hopf G; Mathias B
    Lancet; 1988 Nov; 2(8620):1143. PubMed ID: 2903358
    [No Abstract]   [Full Text] [Related]  

  • 7. Methotrexate in pregnancy.
    Lloyd M; McElhatton P; Carr M; Hall G; Hughes R
    Rheumatology (Oxford); 2005 May; 44(5):697; author reply 698. PubMed ID: 15797976
    [No Abstract]   [Full Text] [Related]  

  • 8. Azathioprine teratogenicity: review of the literature and case report.
    Gebhardt DO
    Obstet Gynecol; 1983 Feb; 61(2):270. PubMed ID: 6823371
    [No Abstract]   [Full Text] [Related]  

  • 9. Does the teratogenicity of isotretinoin outweigh its benefits?
    Jordan AY; Parks L; Chen SC; Higgins K; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2005; 16(4):190-2. PubMed ID: 16249139
    [No Abstract]   [Full Text] [Related]  

  • 10. Efavirenz is not a known teratogen.
    Ford N; Calmy A
    Pediatr Infect Dis J; 2012 Sep; 31(9):999; author reply 1000. PubMed ID: 22609611
    [No Abstract]   [Full Text] [Related]  

  • 11. When a uniquely effective drug is teratogenic. The case of isotretinoin.
    Stern RS
    N Engl J Med; 1989 Apr; 320(15):1007-9. PubMed ID: 2522591
    [No Abstract]   [Full Text] [Related]  

  • 12. Methotrexate exposure prior to and during pregnancy.
    Donnenfeld AE; Pastuszak A; Noah JS; Schick B; Rose NC; Koren G
    Teratology; 1994 Feb; 49(2):79-81. PubMed ID: 8016747
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of suspected isotretinoin-induced malformation in a baby of a mother who became pregnant one month after discontinuation of the drug.
    Lee SM; Kim HM; Lee JS; Yoon CS; Park MS; Park KI; Namgung R; Lee C
    Yonsei Med J; 2009 Jun; 50(3):445-7. PubMed ID: 19568610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When a uniquely effective drug is teratogenic: the case of isotretinoin.
    N Engl J Med; 1989 Sep; 321(11):756-8. PubMed ID: 2770803
    [No Abstract]   [Full Text] [Related]  

  • 15. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.
    Schaefer C; Meister R; Weber-Schoendorfer C
    Arch Gynecol Obstet; 2010 Feb; 281(2):221-7. PubMed ID: 19444462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of isotretinoin embryopathy with bilateral anotia and Taussig-Bing malformation.
    Ceviz N; Ozkan B; Eren S; Ors R; Olguntürk R
    Turk J Pediatr; 2000; 42(3):239-41. PubMed ID: 11105626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric crying face in a newborn with isotretinoin embryopathy.
    Sarici D; Akin MA; Kurtoglu S; Uzum K; Kiraz A
    Pediatr Dermatol; 2013; 30(6):e289-90. PubMed ID: 22612313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy.
    Feldkamp M; Carey JC
    Teratology; 1993 Jun; 47(6):533-9. PubMed ID: 8367826
    [No Abstract]   [Full Text] [Related]  

  • 19. Accutane-induced teratogenesis.
    CMAJ; 1986 Feb; 134(4):308. PubMed ID: 3455832
    [No Abstract]   [Full Text] [Related]  

  • 20. Methotrexate and misoprostol to terminate early pregnancy.
    Yankowitz J; Niebyl JR
    N Engl J Med; 1996 Feb; 334(6):399; author reply 400. PubMed ID: 8538716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.